Contact Us

Experimental drug slows progression of Alzheimer’s: Study

An experimental Alzheimer's drug from Eisai and Biogen slowed cognitive decline in a closely watched trial but may carry a risk of serious side effects for certain patients, according to detailed data presented on Tuesday.

  • 2
  • 8
The drug's developers, Biogen from the U.S. and Eisai from Japan, published results of the study on Tuesday showing the drug as one of the first experimental drugs that slows the progression of cognitive decline.